Jeffrey Poulton V.

Companies

• CervoMed Inc.Board member Aug 23, 2023 to now¹
• Alnylam PharmaceuticalsChief financial officer Aug 13, 2019 to now²
• Q32 Bio Inc.Board member Jul 21, 2020 to Jun 15, 2023³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Alnylam Pharmaceuticals ALNY61,862 shares⁴$14.6M at $235.58Mar 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 4, 2026Sold 223 shares at $325.67 of Alnylam Pharmaceuticals⁴
• Mar 4, 2026Sold 291 shares at $324.88 of Alnylam Pharmaceuticals⁴
• Mar 4, 2026Sold 818 shares at $323.84 of Alnylam Pharmaceuticals⁴
• Mar 4, 2026Sold 374 shares at $323.01 of Alnylam Pharmaceuticals⁴
• Mar 4, 2026Sold 309 shares at $321.82 of Alnylam Pharmaceuticals⁴
• Mar 4, 2026Sold 230 shares at $320.81 of Alnylam Pharmaceuticals⁴
• Mar 4, 2026Sold 109 shares at $320.01 of Alnylam Pharmaceuticals⁴
• Mar 4, 2026Sold 114 shares at $319.03 of Alnylam Pharmaceuticals⁴
• Mar 2, 2026Sold 53 shares at $332.64 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Sold 129 shares at $331.93 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Sold 112 shares at $330.85 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Sold 234 shares at $329.71 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Sold 138 shares at $328.71 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Sold 454 shares at $327.67 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Sold 541 shares at $326.81 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Sold 356 shares at $325.63 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Sold 124 shares at $324.65 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Sold 65 shares at $323.62 of Alnylam Pharmaceuticals⁵
• Mar 2, 2026Granted 4,769 shares of Alnylam Pharmaceuticals⁵
• Feb 27, 2026Exercised options 1,908 shares of Alnylam Pharmaceuticals⁶
• Feb 13, 2026Sold 2,242 shares at $310.08 of Alnylam Pharmaceuticals⁷
• Feb 12, 2026Granted 4,579 shares of Alnylam Pharmaceuticals⁷
• Jan 12, 2026Sold 27 shares at $377.82 of Alnylam Pharmaceuticals⁸
• Jan 12, 2026Sold 34 shares at $375.65 of Alnylam Pharmaceuticals⁸
• Jan 12, 2026Sold 25 shares at $374.44 of Alnylam Pharmaceuticals⁸